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Summa~ 
The absorption mechanism of several penicillins was characterized using in situ single-pass intestinal perfusion in the rat. The 
intrinsic membrane absorption parameters were determined using a modified boundary layer model (fitted value rf: SE.): 
J* max = 11.78 + 1.88 mM, K, = 15.80 + 2.92 mM, P,* = 0, PC* = 0.75 f 0.04 for ampicillin; J,*, = 0.044 f 0.018 mM, K, = 0.058 f 
0.026 mM, P,* = 0.558 + 0.051, PC* = 0.757 rt 0.088 for amoxicillin; and J,& = 16.30 rfr 3.40 mM, K, = 14.00 f 3.30 mM, P,* = 0, 
P,* = 1.14 f 0.05 for cyclacillin. All of the aminopenicillins studied demonstrated saturable absorption kinetics as indicated by their 
concentration-dependent wall permeabilities. Inhibition studies were performed to confirm the existence of a nonpassive 
absorption mechanism. The intrinsic wall permeability (P,*) of 0.01 mM ampicillin was significantly lowered by 1 mM amoxicillin 
and the P,* of 0.01 mM amoxicillin was reduced by 2 mM cephradine consistent with competitive inhibition. 
The wali permeability, which is determined 
from steady-state perfusion experiments in the 
rat intestine, has been shown to be a key variable 
controlling oral drug absorption (Amidon et al., 
1988). It was found that there is a good correla- 
tion between the fraction dose absorbed in hu- 
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mans and the dimensionless wall pe~eabili~ 
(P,*), irrespective of the mechanism of absorp- 
tion, and that P,* might be useful for estimating 
oral drug absorption. 
A modified boundary layer analysis has been 
developed by Johnson and Amidon (1988) in or- 
der to estimate the intrinsic membrane absorp- 
tion parameters. To characterize the absorption 
mechanism of various p-lactam antibiotics, an in 
situ single-pass intestinal perfusion technique in 
rats was used and the intrinsic membrane param- 
eters of some ceph~~osporins were dete~ined 
(flu et al., 1988; Sinko and Amidon, 1988). 
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The p-lactam aminopenicillins, such as ampi- 
cillin, amoxicillin, and cyclacillin, are relatively 
well absorbed from the small intestine. Since they 
are ionized at the physiological pH and have low 
partition coefficients, it has been suggested that 
the mechanism of intestinal absorption of the 
aminopenicillins may be a saturable absorption 
process in the rat (Dixon and Mizen, 1977; Tsuji 
et al., 1977, 1978, 1981a,b; Kimura et al., 1978, 
1983; Shindo et al., 1978; Iseki et al., 1984; 
Nakashima et al., 1984). However, there are con- 
flicting reports in the literature on the absorption 
mechanism. Some investigators reported the pas- 
sive absorption of ampicillin (Penzotti and Poole, 
1974; Dixon and Mizen, 1977; Miyazaki et al., 
1977; Kimura et al., 1978; Tsuji et al., 1981a; Iseki 
et al., 1984), amoxicillin (Dixon and Mizen, 1977; 
Miyazaki et al., 1977), and cyclacillin (Penzotti 
and Poole, 1974). Recently, human oral absorp- 
tion data have suggested the existence of a capac- 
ity-limited transport system for aminopenicillins 
(Sjovall, 1985a). 
In this report, the intrinsic parameters of some 
aminopenicillins were determined by carrying out 
single-pass perfusion experiments in rats. Inhibi- 
tion studies were performed to confirm the exis- 
tence of carrier-mediated absorption of amino- 
penicillins including ampicillin. 
Experimental 
Materials 
Ampicillin, amoxicillin, and urethane were 
purchased from Sigma Chemical Co. (St. Louis, 
MO). Cyclacillin was supplied by Wyeth-Ayerst 
(Philadelphia, PA). Polyethylene glycol (PEG) 
3350 was obtained from Fisher Scientific (Fair 
Lawn, NJ), and [14C]PEG 4000 from New Eng- 
land Nuclear (Boston, MA). Citric acid and 
sodium chloride were purchased from Mallinck- 
rodt, Inc. (Paris, KY). Monobasic potassium 
phosphate, acetonitrile, and dibasic sodium phos- 
phate were obtained from J.T. Baker Chemical 
Co. (Phillipsburg, NJ). All chemicals were analyti- 
cal or HPLC grades. Ecolite (+ 1, a liquid scintil- 
lation cocktail, was supplied by ICN Biomedicals, 
Inc. (Cleveland, OH). 
An appropriate amount of the compound to be 
studied was dissolved in a citric acid-dibasic 
sodium phosphate buffer, of which the pH was 
adjusted to 6.5 (Beckman pH meter, Fullerton, 
CA) and the osmolality to 300 + 5 mosM/kg 
(Wescor Model 5500 vapor pressure osmometer, 
Logan, UT). PEG 3550 (0.01% w/v) with a trace 
amount of [ i4C]PEG 4000 was added to the per- 
fusion solution. 
In situ single-pass rat perfusion experiments 
Male Charles River rats (250-420 g, age 60-90 
days) were fasted for 15-18 h prior to each exper- 
iment. Water was given ad libitum. Anesthesia 
was induced by an intraperitoneal injection of a 
50% (w/v) urethane solution (1.6 g/kg). The 
jejunum was cannulated at 2-4 cm below the 
ligament of Treitz and about 10 cm distal to the 
first incision. The intestinal segment was per- 
fused using a constant infusion pump (Harvard 
Apparatus, Model 931, South Natick, MA) for 2 
h. The perfusate was maintained at 37 k 1°C by a 
water bath (Tek-Pro, American Dade, Miami, 
FL). During the experiment the rat was kept on a 
Precision slide warmer (GCA Co., Chicago, IL), 
and the abdomen was covered with a saline- 
wetted paper towel and a piece of Parafilm 
(American Can Co., Greenwich, CT). The perfu- 
sion flow rate was 0.123 or 0.191 ml/min. Steady 
state was achieved in approx. 30 min, after which 
six samples were taken at 15-min intervals. After 
the last sample was taken, the length of the 
intestine was measured by placing a piece of 
string along the intestine and measuring the string 
with a ruler. 
For the inhibition studies, two segments of the 
rat jejunum were perfused simultaneously to serve 
as a control. The second segment was distal to 
the first segment. The data are reported as means 
(k S.E.) from three to five rats with two to five 
determinations per rat. 
Analytical methods 
For the water flux measurement, 0.5 ml of the 
sample was mixed with 15 ml of scintillation 
cocktail. The samples were counted on a Beck- 
man LS-9000 counter (Beckman Instruments Inc., 
Fullerton, CA). 
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The samples were analyzed by high-perfor- 
mance liquid chromatography (HPLC). The 
HPLC instrumentation consisted of a pump 
(Spectroflow 400, Kratos Analytical Instruments, 
Ramsey, NJ), an automatic injector (Waters 712 
WISP, Millipore Co., Milford, MA), a reverse- 
phase column (Partisil lo-ODS, 25 cm, Whatman 
Inc., Clifton, NJ), a UV detector (Spectroflow 783 
or 773, Kratos Analytic Instruments, Ramsey, NJ), 
and an integrator (Model 3390A, Hewlett-Packard 
Co., Avondate, PA). The mobile phase consisted 
of acetonitrile and 0.01 M monobasic potassium 
phosphate (pH 6.1) in the ratio of lo:90 and 
5 : 95 for ampicillin and amoxicillin, respectively, 
and acetonitriie, methanol, and monobasic potas- 
sium phosphate in the ratio of 19 : 11: 70 for 
cyclacillin. The flow rate was 1.2 ml/min, and the 
UV wavelength was 215 nm for ampicillin and 
225 nm for amoxicillin and cyclacillin. The con- 
centration was determined from the peak height. 
Data Analysis 
Water transport 
Assuming that [14C]PEG 4000 will not be ab- 
sorbed from the intestine, the percentage of wa- 
ter transport per centimeter length perfused for 
each sample was calculated from 
% water transport/cm 
300 (A* --lib) - (A, -AJ 
=-. 
L 4-n -4 
(1) 
where A,, A,, and A, represent the disintegra- 
tions per min (dpm) of the inlet, outlet, and blank 
samples, respectively. 
Water transport below 0.5%/cm of intestinal 
length was considered normal and experiments at 
higher rates of water transport were not used for 
the determination of the permeability parame- 
ters. The perfusate outlet concentrations were 
corrected using Eqn 1. 
E~tirn~t~o~ of ~~tri~ic membrffne parameters 
The intrinsic membrane abso~tion parame- 
ters were estimated using a modified boundary 
model approach developed by Johnson and Ami- 
don (1988). Assuming that the difference between 
the rate of mass flowing into and out of the 
intestine is equal to the rate of mass absorbed, 
the dimensionless * effective wall permeability, 
P& is calculated from the steady-state perfusion 
results: 
(2) 
where C, and C, represent the inlet and outlet 
perfusate concentrations, respectively, and the 




where D denotes the diffusion coefficient, L is 
the length of the intestine perfused, and Q repre- 
sents the fluid flow rate. The dimensionless aque- 
ous permeability, P& is estimated from the film 
model approximation to the boundary layer re- 
sults: 
1 
Pa; = A . Czl/3 ’ 
where 
i 
lO.OOGz c 1.010 0.004 Q Gz < 0.01 
A = 4SOGz i- 1.065 0.010 < Gz < 0.03 (5) 
2SOGz f 1.125 0.030 < Gz 
The wall concentration, C,, and the dimen- 
siontess wall permeability, P,*, are then calcu- 








* The multiplication of the parameter by R/D results in 
the dimensionless parameter where R is the radius of the 
intestine and D denotes the diffusion coefficient. 
* * In the engineering literature Gz is traditionally defined,as 
the inverse of Eqn 3. 
184 
The dimensionless flux at steady state, JSz, is 
expressed as: 
J: =P,*-C,, 
and for a combination of carrier and passive 
transport mechanisms P,* is assumed to be of the 
form: 
where J,& and K, are the maximal flux and the 
intrinsic Michaelis constant for the carrier trans- 
port, respectively, and P,* represents the intrin- 
sic passive membrane pe~eabili~. The dimen- 
sionless carrier permeability, P,* is defined as 
J* 
p=* = max. 
Kn 
(W 
0.0 L---d -I “_..( ,...d uIJ 
0.001 0.010 0.100 1.wo lO.ooo 100.000 
Cw (mM) 
1.5 r c 
1.0 - 
From Eqns 9 and 10, 
(11) 
The corrected ~ncentration ratio (C,/C,) was 
kept between 0.85 and 0.95 to estimate the per- 
meability parameters (Johnson and Amidon, 
1988). 
Estimation of the aqueous diffusion coefficients 
The diffusion coefficients used in the evalua- 
tion of the permeabilities were calculated accord- 
ing to the Hayduk-Laudie expression (Reid et al., 
1977): 
D = 13.26 x 10-s ?-j - 1.4~789 
(12) 
0.0 L 
o.ooo1 0.0010 0.0100 O.looo lm3o 1oBooo 
Cw (mM) 
0.0 ’ ‘,,.‘,” _,‘.I ““‘,‘I ‘.,.&.A 
0.01 0.10 1.00 10.00 100.00 
Cw (m&f) 
Fig. 1. Intrinsic wall permeability (I’,*) vs wall concentration (C,) of ampicillin (A), amoxicillin (B), and cyclacillin (Cc) in rat 
jejunum: (H) experimental data (mean f SE.1 from three to five rats with two to five determinations per rat; (- ) best fit line. 
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where n denotes the viscosity of water (0.6915 CP 
at 37”C), V, is the solute molal volume at normal 
boiling point (cm3/g per mol), and D denotes the 
binary diffusion coefficient at infinite dilution 
(cm2/s). Molal volumes were estimated using 
Schroeder’s additive method. The values of V” 
and D are 315 and 0.00045 cm2/min for ampi- 
cillin, 322 and 0.00044 cm2/min for amoxicillin, 













Results and Discussion 
Intrinsic wall permeabilities of ampicillin, am- 
oxicillin, and cyclacillin show a dependence on 
concentration, suggesting the existence of a sat- 
urable absorption mechanism in rat jejunum (Fig. 
1). The experimental data were fitted to Eqn 9 or 
11 using a weighted nonlinear regression to ob- 
tain the absorption parameters (Sink0 and Ami- 
don, 1988). A summary of the intrinsic absorption 
parameters is given in Table 1. The intrinsic 
carrier permeabilities of ampicillin (0.75 &- 0.04) 
and amoxicillin (0.76 f 0.09) are shown to be 
about the same, but less than that of cyclacillin 
(1.14 k 0.05). The K, of amoxicillin is several 
hundred times lower than that of ampicillin and 
cyclacillin, suggesting a higher affinity to the car- 
rier transport system. A similar result for amoxi- 
cillin in rat intestine was reported by Nakashima 
et al. (1984). Amoxicillin exhibits significant pas- 
sive transport in addition to the carrier-mediated 
pathway. A different experimental result for 
amoxicillin was reported (Sinko, 1988). It is not 
yet clear why the permeability profiles of ampi- 
- 
0 Second Segment 
Cl First Sogmont 
Rat 1 Rat 2 Rat 3 
Fig. 2. Differences of the intrinsic wall permeabilities of 0.01 
mM ampicillin between two rat jejunum segments (mean + SE. 
from two to five determinations). The p value from a paired 
t-test was 0.267. 
cillin and amoxicillin are different even though 
their structures are similar. 
There are few reports on carrier-mediated 
transport of ampicillin in rat intestine. Shindo et 
al. (1978) reported that the absorption of ampi- 
cillin in rat intestinal loop showed a tendency 
toward saturation at a dose above 3 mg per loop 
which was about 15 mM. It was shown .that the 
intestinal absorption of cephradine and cephalex- 
in was inhibited by ampicillin to some extent as 
well as by amoxicillin and cyclacillin (Miyazaki et 
al., 1982). The results of the present study indi- 
cate that the primary absorption mechanism of 
ampicillin in rat intestine is nonpassive. 
The inter-rat variation can cause difficulty in 
estimating permeability when the compound has 
a relatively low P,*. To minimize this problem, 
two segments of rat jejunum were used to obtain 
TABLE 1 
Summary of the intrinsic wall permeability parameters for secleral penicillins in the rat intestine in situ 
Compounds J&. &I p,* p,* 
(mM) (mM) 
Ampicillin 11.78 f 1.88 a 15.80 f 2.92 ND0 b 0.75 f 0.04 
Amoxicillin 0.044 + 0.018 0.058 f 0.026 0.558 f 0.051 0.757 f 0.088 
Cyclacillin 16.30 + 3.40 14.00 f 3.30 ND0 1.14 & 0.05 
a Fitted value + SE. 
b ND0 = not different from zero. 
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paired data. Fig. 2 shows that the difference of 
P,* of 0.01 mM ampicillin between two segments 
was not significant (p = 0.2671, suggesting the 
homogeneous distribution of a transport system 
throughout the rat jejunum. Similarly, the perme- 
abilities of amoxicillin and cyclacillin showed no 
differences between two segments. For inhibition 
studies two segments were used alternately for 
the compound alone and the compound with an 
inhibitor. 
Mutual inhibition studies on the absorption of 
/3-lactam antibiotics and/or some dipeptides have 
shown that they share at least one carrier-media- 
ted system (Kimura et al., 1978; Miyazaki et al., 
1982; Iseki et al., 1984; Nakashima et al., 1984; 
Inui et al., 1988; Sinko and Amidon, 1989). 
The results of coperfusion of ampicillin and 
amoxicillin are presented in Table 2. The concen- 
tration of amoxicillin used as an inhibitor was 1 
mM which is much higher than its K, value. The 
P,* of 0.01 mM ampicillin was significantly low- 
ered by amoxicillin (p = 0.014). Kimura et al. 
(1978) reported that the simultaneous perfusion 
of 0.1 or 1.0 mM amoxicillin did not inhibit the 
absorption of 0.1 mM ampicillin. However, the 
variability in P, is high and the paired studies 
used in this report are more sensitive to differ- 
ences. Table 3 shows that the P,* of 0.01 mM 
amoxicillin was significantly reduced by 2 mM 
cephradine. It has been reported by Iseki et al. 
(1984) that the absorption of amoxicillin is signifi- 
cantly inhibited by cyclacillin, cephradine, and 
cephalexin, and that the inhibitory tendency of 
ampicillin on amoxicillin absorption is also ob- 
TABLE 2 
Inhibition of wall permeability of ampicilhn CO.01 mM) by 
co-perfusion with 1 mM amoxicillin in the rat jejunum 
Rat Wall permeability (P,*J Difference’ 
Without inhibitor With inhibitor 
1 1.41*0.17= 1.10+0.14 0.31 
2 1.10+0.03 0.82 f 0.04 0.28 
3 0.74 f 0.09 0.63 kO.08 0.11 
4 1.12*0.21 0.91 f0.12 0.21 
a Mean + SE. from hvo to five determinations. 
h p < 0.02 by a paired t-test. 
TABLE 3 
Inhibition of wall permeability of amoxicillin (0.01 mM) by 
co-perfusion with 2 mM cephradine in the rat jejunum 
Rat Wall permeability (I’,*) Difference b 
Without inhibitor With inhibitor 
1 1.37 * 0.22 = 0.99kO.14 0.38 
2 1.27 + 0.04 0.95&0.17 0.32 
3 1.45 f 0.06 1.22+0.14 0.23 
a Mean + S.E. from hvo to five determinations. 
b p < 0.02 by a paired t-test. 
served in the rat. Dose-dependent absorption of 
amoxicillin (Spyker et al., 1977; Sjovall et al., 
1985b) and ampicillin (Magni et al., 1978; Sjovall, 
1979) has been observed in the human and the 
interaction between aminopenicillins investigated 
@j&all et al., 1985). Their findings and our re- 
sults support the contention that the /I-lactam 
aminopenicillins are absorbed via a carrier-medi- 
ated process combined with a parallel passive 
process and that there exists a common carrier 
system for /3-lactam antibiotics. 
In summary, our results have shown that the 
wall permeabilities of ampicillin, amoxicillin, and 
cyclacillin are concentration-dependent in rat je- 
junum. For inhibition studies, two segments of rat 
jejunum were used for reducing inter-rat varia- 
tions. Inhibition studies confirmed the existence 
of a carrier-mediated mechanism of aminopeni- 
cillins. 
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